QUOTE AND NEWS
Penny Stock DD  Nov 25  Comment 
CardioVascular BioTherapeutics, Inc. (PINK:CVBT)reported the fall of 5.32% and closed at $0.44 whereas overall traded volume stood at 639,773 shares as compare to its average volume stood at 167,788. Its total market capitalization ended at $68.84...
MarketWatch  Jan 5  Comment 
Shares of Glaxo are sliding in the wake of a negative report aired by “60 Minutes” while Opexa shares rally on a positive update for its MS drug candidate Tovaxin.
StreetInsider.com  Nov 30  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/CardioVascular+%28CVBT%29+Signs+Exclusive+Licensing+Agreement+with+Merck+%28MRK%29+Affiliate/6133099.html for the full story.




RELATED WIKI ARTICLES

Related Articles

 


CardioVascular BioTherapeutics, Inc. (OTCBB: CVBT) or ("Cardio") is a development stage biopharmaceutical company focused on developing and marketing protein drug candidates that are designed to be used in the treatment of cardiovascular disease. The Company was incorporated in Delaware on March 11, 1998 (“Inception”) as CardioVascular BioTherapeutics, Inc. Since inception, the Company has been engaged in research and development activities associated with bringing its products to market.[1]




References

  1. Form 10-Q, Note 1. Description of Business
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki